Similar articles

• Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.

  Banks E, Canfell K. Banks E, et al. Am J Epidemiol. 2009 Jul 1;170(1):24-8. doi: 10.1093/aje/kwp113. Epub 2009 May 25. Am J Epidemiol. 2009. PMID: 19468078
• [Joint position statement of Polish Gynecologic Society, Polish Cardiological Society, and Polish Menopause and Andropause Society on the effect of hormone replacement therapy on cardiovascular system].

  Kornacewicz-Jach Z, Czarnecka D, Rynkiewicz A, Kotarski J, Paszkowski T, Pertyński T, Debski R, Wielgoś M. Kornacewicz-Jach Z, et al. Kardiol Pol. 2009 Jan;67(1):72-6. Kardiol Pol. 2009. PMID: 19253195 Polish. No abstract available.
• From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health.

  Gambacciani M, Genazzani AR. Gambacciani M, et al. Gynecol Endocrinol. 2006 Mar;22(3):115-6. doi: 10.1080/09513590600676903. Gynecol Endocrinol. 2006. PMID: 16835071 No abstract available.
• Surgical menopause, estrogen, and cognitive function in women: what do the findings tell us?

  Sherwin BB. Sherwin BB. Ann N Y Acad Sci. 2005 Jun;1052:3-10. doi: 10.1196/annals.1347.001. Ann N Y Acad Sci. 2005. PMID: 16024746 Review.
• Hormonal management of migraine at menopause.

  Nappi RE, Sances G, Detaddei S, Ornati A, Chiovato L, Polatti F. Nappi RE, et al. Menopause Int. 2009 Jun;15(2):82-6. doi: 10.1258/mi.2009.009022. Menopause Int. 2009. PMID: 19465675 Review.